AN OPTION FOR CYSTIC FIBROSIS PATIENTS AFFECTED BY CHANGE IN LIMITED DISTRIBUTION NETWORK FOR CAYSTON MEDICATION
Lubbock, Texas – May 4, 2015 – Gilead Sciences, Inc. and Cystic Fibrosis Services, Inc. (CFS) mutually agreed that CFS will transition out of the pharmacy network for Cayston®distribution. Beginning January 1, 2015, this change will start the shift of patients to one of the other U.S. specialty pharmacies that provide Cayston®.
Used to improve both respiratory symptoms and lung function of Cystic Fibrosis patients 7 years and older, Cayston® (aztreonam for inhalation solution) is an antibiotic that helps fight Pseudomonas aeruginosa bacterial infections. Cayston® is delivered directly into the lungs in the form of a breathing treatment with the Altera® Nebulizer System. “IV Solutions is a full service inhalation and infusion pharmacy that has been one of the national limited distributors for Cayston® since its launch in 2010.” said Jan Robinson, Vice President of Operations for Maxor Speciality and IV Solutions.
Cystic Fibrosis, or CF, is a genetic disease affecting over 30,000 Americans. The illness prevents the lungs and digestive system from working properly. Currently, there is no cure for CF. However, early diagnosis with a comprehensive treatment plan coupled with regular clinical monitoring and follow-ups are the best treatment options to improve survival rates and overall quality of life.
IV Solutions is a division of Maxor National Pharmacy Services. Founded in 1986, “IV Solutions provides the unique one-on-one support needed for our patients and caregivers to better understand and manage their complex condition. Our personalized, high touch approach strives to improve patient outcomes and empower our patients to live fuller, happier and more productive lives.” says Jan Robinson.
With Maxor’s nationwide distribution system, IV Solutions is equipped to deliver personalized pharmacy services to the people who need them most. IV Solutions also provides 24 / 7 patient support, on-call pharmacists, and reimbursement assistance to those in need.
The company’s blog and Facebook presence are dedicated to educating the public about Cystic Fibrosis. Click here to learn more about Cayston and IV Solutions. For full dosing and prescribing information, please visit www.cayston.com/.
Press Release for Change in Cayston Pharmacy Distribution Network. Gilead Sciences, Inc. December 22, 2014. Accessed April 24, 2015.